Cardiac function and outcome in patients with cardio-embolic stroke by 源��쁺��
Cardiac Function and Outcome in Patients with Cardio-
Embolic Stroke
Jung-Ick Byun1, Keun-Hwa Jung1 , Young-Dae Kim2, Jeong-Min Kim3, Jae-Kyu Roh4
1Department of Neurology, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea; Program in Neuroscience, Seoul National University College
of Medicine, Seoul, South Korea, 2Department of Neurology, Yonsei University College of Medicine, Seoul, Korea, 3Department of Neurology, ChungAng university
hospital, Seoul, Korea, 4Department of Neurology, Armed Forces Capital Hospital, Seongnam, Gyeunggido, South Korea
Abstract
Background: The relationship between whole spectrum of Ejection fraction (EF) and cardioembolic stroke (CES) outcome
has not been fully described yet. Notably, it remains unclear whether borderline EF (41,49%) is related with poor outcome
after CES. We sought to evaluate whether lower ejection fraction and borderline EF could predict the outcome in patients
with CES.
Method and Results: We evaluated the relationship between EF and functional outcome in 437 consecutive patients with
CES. EF was introduced as continuous and categorical (EF#40%, EF 41,49%, EF$50%) variable. Patients with CES and the
subgroup with AF were evaluated separately. Poor short-term outcome (modified Rankin Score$3at discharge or death
within 90 days after stroke onset) and long-term mortality were evaluated. A total of 165 patients (37.8%) had poor short-
term outcomes. EF tends to be lower in patients with poor short-term outcome (56.8611.0 vs. 54.8612.0, p-value 0.086).
Overall cumulative death was136 (31.1%) in all CES patients and 106 (31.7%) in the AF subgroup. In a multivariable model
adjusted for possible covariates, the hazard ratio for mortality significantly decreased by 3% for every 1% increase in
ejection fraction in CES patients and 2% for every 1% increase in the AF subgroup. Reduced EF (EF#40%) showed higher
mortality (HR 2.61), and those with borderline EF (41,49%) had a tendency of higher mortality (HR 1.65, p-value
0.067)compared with those with normal EF.
Conclusion: We found a strong association between lower EF and CES outcome. Echocardiographic evaluation helps to
better determine the prognosis in CES patients, even in subgroup of patients with AF.
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Introduction
Heart disease is a major risk factor for stroke following age and
hypertension [1]. Ejection fraction (EF), the proportion of left
ventricular volume emptied during ventricular systole, is a reliable
measure of left ventricular (LV) systolic function [2]. Reduced EF
provides objective documentation of cardiac dysfunction [3].Pre-
vious studies identified low EF as a predictor of mortality in stroke
patients [4–6]. However, there are limitations in the previous
studies. First, EF was arbitrarily dichotomized and evaluated as a
categorical variable. In consequence, the relationship between full
spectrum of EF and stroke outcome was not properly evaluated,
especially those with borderline EF. Second, previous studies
evaluated stroke patients regardless of its subtype. Cardioembolic
stroke (CES) is known to cause more severe stroke [7,8] and higher
mortality [9,10] than other stroke subtypes. Moreover, atrial
fibrillation (AF), the most common source of CES [11], is known
to be independently associated with higher case fatality in CES.
Decreased EF may have more impact on CES outcome, especially
on those with AF. This study attempted to address this
shortcoming by exploring the influence of EF as continuous and
categorical variable in patients with CES. We sought to evaluate
whether lower ejection fraction and borderline EF could predict
outcome in patient with CES and in subgroup with AF.
Methods
Ethics statement
The guidelines and procedures of this registry were approved by
the Institutional Review Board of the Seoul National University
Hospital. Written informed consent to participate was obtained
from all patients or their next of kin if the inclusion criteria were
met.
Study population
We performed a retrospective cohort study based of consecutive
patients with CES. Among acute stroke patients consecutively
registered in the Seoul National University Hospital Stroke
Registry (SNUHSR) between January 2002 and December
2010, those with cardioembolism subtype were included in this
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e95277
* *
study. Patients with transient ischaemic symptom or those without
documented EF measurement were excluded. The SNUHSR is a
prospective hospital based registry for patients with acute ischemic
stroke or transient ischemic attack admitted within 7 days after
symptom onset. The registry dataset included information of
demographics, stroke subtypes, vascular risk factors, investigations
performed in the hospital and neurological outcomes at discharge.
Clinical, radiological and laboratory evaluations allowed us to
disclose the stroke etiology and the diagnosis of CES was made
according to the Trial of ORG10172 in Acute Stroke Treatment
(TOAST) classification [12].
Vascular risk factors and cardiac evaluation
We collected demographics, vascular risk factors and in-
hospital evaluation and management for each patient. Vascular
risk factors included history of previous stroke, hypertension,
diabetes mellitus, hyperlipidemia and smoking. Hypertension was
defined as a systolic blood pressure .140 mm Hg, a diastolic
blood pressure .90 mm Hg and/or current use of anti-
hypertensive agents. Diabetes mellitus was diagnosed by the
relevant clinical or drug history or the biochemical evidence of at
least two measurements of fasting blood glucose readings .
7 mmol/L. Dyslipidemia was defined as current use of lipid-
lowering agents or at least two elevated serum lipid measurements
(total cholesterol .6.2 mmol/L or low-density lipoprotein-choles-
terol.4.1 mmol/L). Smoking was defined as tobacco use within 1
month of admission [13]. Hemorrhagic transformation was
documented when initial or follow-up brain imaging revealed
hemorrhage on the site of ischemic stroke. The severity of the
stroke was evaluated by a trained neurologist using National
Institute of Health Stroke Scale (NIHSS) and disability was
accessed using modified Rankin score (mRS) at admission and at
discharge. NIHSS is a 11-item neurologic examination stroke scale
for use in acute stroke therapy trials [14].The modified Rankin
scale is a commonly used scale measuring disability or dependence
in activities of daily life in stroke patients [15].
Standard cardiac evaluation included 12-lead electrocardiogra-
phy (ECG)and transthoracic echocardiography. Holter monitoring
or transesophageal echocardiography was performed when
standard cardiac evaluation did not reveal any cardioembolic
source in high clinical suspicion of CES. Diagnosis of AF was
made when there was a documented history of paroxysmal AF or
ECG data showing AF during hospitalization. Both chronic and
paroxysmal AF was included. Echocardiogram was performed
with the patient resting supine in the left lateral position during
hospital admission and interpreted by a trained cardiologist. EF
was calculated by biplane modified Simpson’s method [16].
Outcome parameters
Poor short-term functional outcome and long-term mortality
were evaluated. Poor short-term outcome was characterized by
mRS$3at discharge or death within 90 days after stroke onset.
Mortality data were obtained from the Korean National Vital
Statistics system with currency of December 2010. In Korea, all
deaths must be reported to the National Vital Statistical Office by
law and the data are known to be reliable [17].
Statistical analysis
Statistical analysis was performed to evaluate the relationship
between EF and outcome parameters. Patients with CES and the
subgroup with AF were evaluated separately. All data in this study
are expressed as mean 6 standard deviations (SD) or numbers
(percentages). Continuous variables were tested for normal
distribution with the Kolmogorov-Smirnov test. Mann-Whitney
U test was used to compare EF according to short-term functional
outcome. EF according to mRS and 90 days mortality was
separately analyzed using Kruskal-Wallis one-way analysis of
variance and Mann-Whitney U test respectively. Predictors for
outcome were determined by multivariate logistic regression
analysis. All variables except for age, EF and NIHSS were
dichotomized. EF was first introduced as continuous variable. And
we divided EF into three groups (#40%, 41,49%, .50%) and
introduced it as a categorical variableto further evaluate the
relationship between EF and CES outcome. Age was introduced
as continuous variable and NIHSS was categorized into three
groups following the usual criteria [18]: NIHSS score ,7, NIHSS
7–14 and NIHSS score .14. Comparisons between groups were
analyzed as follows: continuous variables by Student’s t-test
(2-sided) or Mann-Whitney U test and categorical variables by
Pearson’s chi square test. Variables with p-value ,0.1 in
univariate analysis were entered into the multivariate model.
To identify relationship between EF and long-term mortality,
we first used multivariate Cox regression model introducing EF as
a continuous variable. The model adjusted possible predictors of
mortality and morbidity including age, sex, previous history of
stroke, hypertension, diabetes, dyslipidemia, smoking, NIHSS at
admission, intra-venous or intra-arterial thrombolysis, hemorrhag-
ic transformation and warfarin at discharge. To further evaluate
the relationship between EF and long-term mortality, we divided
the range of EF into 3 groups as previously described: normal (.
50%), borderline (41–49) and reduced (#40%) [3]. Kaplan-Meier
analysis was used to estimate survival condition and the log-rank
test was used to compare rate estimates according to EF. The same
Cox regression model was applied to evaluate relationship
between long-term mortality and the three EF groups. The
variables were cross tabulated to discard multicollinearity.
Probability values of ,0.05 were considered statistically signifi-
cant. SPSS software (SPSS 12.0, SPSS Inc., Chicago, IL, USA)
was used for the analysis.
Results
Patient characteristics and cardiac sources of embolism
Of 2,543 patients registered in SNUHSR between January 2002
and December 2010, 467 patients with CES were initially
enrolled. Thirty patients were excluded from this study: 20 with
transient ischemic symptom and 10 without documented EF.
Finally, a total of 437 patients were included in this study.
(Figure 1) The median age of the patients was 69 years (IQR, 61–
76) and 57.4% were male. Patients in the subgroup with AF were
older, had a higher vascular risk burden and presented with more
severe deficits than those without AF. (Table 1) The mean EF was
56.02611.40% (median EF 57.0%). The distribution of EF is
shown in Figure 2. Patients with decreased EF were predomi-
nantly male, but prevalence of vascular risk factors and stroke
severity were similar between groups. (Table S1 in File S1).
In terms of CES etiology, atrial dysrhythmia without structural
heart disease was documented in 232 (53.1%) patients, structural
heart disease with sinus rhythm in 71 (16.2%) of patients, and
combined disease in 104 (23.8%) patients. The remaining 30
(6.8%) patients showed other etiologies: 3 with LA myxoma, 5
with LA thrombus, 5 with LV thrombus and 16 with PFO. The
most frequent cardiac source of embolism was AF (76.4%),
followed by systolic HF (11.6%). Detailed etiologies of CES are
shown in Table S2 in File S1.
Cardiac Function and Cardioembolic Stroke Outcome
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Functional outcome at discharge and short-term
mortality
The median mRS score at discharge was 2 (IQR, 1–4) in CES
patients and in the AF subgroup. All patients were followed up in
OPD clinic at 3 months and a total 165 patients (37.8%) had poor
short-term outcome. While EF was not significantly different
according to the discharge mRS (p-value 0.124), EF tended to be
lower in patients with poor short-term outcome (56.8611.0 vs.
54.8612.0, p-value 0.086). Twenty seven CES patients (6.2%)
died within 90 days after admission and EF was significantly
higher in the living group. (Figure 3) EF was able to predict 90 day
mortality (adjusted OR 0.94) in the multivariate analysis. Older
age (adjusted OR = 1.05), initial stroke severity (adjusted
OR = 13.18) and warfarin after discharge (OR 0.33) were also
associated with 90 day mortality. In the AF subgroup analysis, the
90 day mortality rate was 6.3% and EF showed a tendency to be
associated with the 90 day mortality (adjusted OR 0.96), along
with the initial stroke severity (adjusted OR 12.63). Age (adjusted
OR 1.06) diabetes (adjusted OR 3.42) and warfarin by discharge
(adjusted OR 0.35) were independently associated with the 90 day
mortality. (Table 2)
Long-term mortality
Overall cumulative death was136 (31.1%) in all CES patients
and 106 (31.7%) in the AF subgroup. The relationship between EF
and long-term mortality is shown in Table 3. In a multivariable
model adjusted for possible covariates, the hazard ratio for mortality
significantly decreased by 3% for every 1% increase in ejection
fraction in CES patients and 2% for every 1% increase in the AF
subgroup. Older patients and those with severe stroke had higher
mortality. Patients with hyperlipidemia and statin prescription were
Figure 1. Flow chart of patient enrollment. Abbreviations:
SNUHSR: Seoul National University Hospital Stroke Registry, CES:
Cardio-embolic stroke, TIA: Transient ischemic attack, EF: Ejection
Fraction.
doi:10.1371/journal.pone.0095277.g001
Figure 2. Distribution of EF in included CES patients. Abbreviations: EF:Ejection fraction, CES: Cardioembolic stroke.
doi:10.1371/journal.pone.0095277.g002
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Table 1. Basic demographics.
Total (n =437) Subgroup with AF Subgroup without AF P value
(n =334) (n=103)
Age (years) 67.2612.9 69.7610.8 59.2615.8 ,0.001
Male 251 (57.4) 182 (54.5) 69 (67.0) 0.025
Previous stroke 88 (20.1) 72 (21.6) 16 (18.2) 0.183
Hypertension 257 (58.8) 214 (64.1) 43 (41.7) ,0.001
Diabetes 115 (26.3) 92 (27.5) 23 (22.3) 0.293
Hyperlipidemia 79 (18.1) 62 (18.6) 17 (21.5) 0.635
Smoking 100 (22.9) 71 (21.3) 29 (28.2) 0.145
Initial NIHSS 0.006
,7 248 (56.8) 177 (53.0) 71 (68.9)
7–14 89 (20.4) 78 (23.4) 11 (10.7)
.14 100 (22.9) 79 (23.7) 21 (20.4)
IV or IA thrombolysis 81 (18.5) 64 (19.2) 17 (16.5) 0.544
Discharge Warfarin 344 (78.7) 275 (82.3) 69 (67.0) 0.001
Hemorrhagic transformation 92 (21.1) 80 (24.0) 12 (11.7) 0.007
Values are mean6SD or number of patients (percentage).
AF: Atrial fibrillation, NIHSS: National Institutes of Health Stroke Scale, IV: Intravenous, IA: Intraarterial,
doi:10.1371/journal.pone.0095277.t001
Figure 3. EF according to short-term functional outcome (A), 90 days mortality (B), and mRS in CES patients (C).
p-value ,0.01. Abbreviations: ns: not significant, EF, Ejection fraction.mRS: modified Rankin Scale, CES: Cardioembolic stroke.
doi:10.1371/journal.pone.0095277.g003
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 ns: not significant, ***:
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protective of long-term cumulative death. (Table 3, Table S3 in File
S1).
Survival curves are illustrated in Figure 4. Patients with reduced
EF (EF#40%) had a significant higher mortality (HR 2.61) than
those with normal EF. Those with borderline EF (41,49%) had
tendency of higher mortality with a lower HR (HR 1.65, p-value
0.067). In the AF subgroup, decreased EF was associated with
higher mortality, but with lower HR and less significance.
Borderline EF was not associated with mortality. Increasing age
and stroke severity were independent predictors of long-term
mortality in both CES patient and AF subgroup. Smoking
significantly increased mortality in the AF subgroup only.
(Table 3, Table S4 in File S1) The mortality data of 34 patients
were missing among 136 patients who died. Among others, 38
(37.3%) had vascular death (fatal stroke with ICD code I60–64 or
ischemic heart disease caused by myocardiac infarction with ICD
code I21–34 as previously defined [19]). Patients with decreased
EF had higher HR with vascular death (HR 3.54, p-value 0.003 in
CES, HR 2.81, p-value 0.064 in AF subgroup).
Discussion
Our results show an inverse relationship between EF and long-
term cumulative mortality not only in CES patients, but also in the
AF subgroup. About 11.7% of our patients had decreased EF
Table 3. Multivariable model hazard ratios for long-term outcomes by EF compared with normal values.
Adjusted HR (95% CI) of long-term mortality
CES patients CES patients with AF
EF (1% increase in EF) 0.97 (0.96–0.99) 0.98 (0.96–1.00)
EF,40% 2.61 (1.64–4.17) 2.30 (1.29–4.11)
EF 40,54% 1.65 (0.97–2.81) 1.48 (0.78–2.81)
EF 55,70% 1.00 (Reference) 1.00 (Reference)
Adjusted for age, sex, history of stroke, hypertension, diabetes, dyslipidemia, smoking,
Admission NIHSS (,7, 7–14, .14), IV or IA thrombolysis,discharge warfarin, hemorrhagic transformation.
EF: Ejection Fraction, CES: cardioembolic stroke, AF: Atrial fibrillation, NIHSS: National Institutes of Health Stroke Scale,
IV: Intra-venous, IA: Intra-arterial.
doi:10.1371/journal.pone.0095277.t003
Figure 4. Kaplan-Meier curves of long-termmortality by EF groups in CES patients (A) and AF subgroup (B). Abbreviations: EF, Ejection
fraction. CES: Cardioembolic stroke, AF: Atrial fibrillation.
doi:10.1371/journal.pone.0095277.g004
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(EF#40%), which is higher than in previous reports (5% to 8%)
[4,5]. Sources of CES were similar compared with previous
studies. Decreased EF (EF#40%) was an important predictor of
mortality in patients with CES and in the AF subgroup. Borderline
EF of 41,49% was a poorer predictor of mortality in CES
patients and was not predictive of mortality in the AF subgroup.
To the best of our knowledge, this is the first study evaluating the
relationship of EF as a full spectrum on functional outcomes after
CES.
Our data revealed a high association between EF and 90 days
mortality which is in line with previous studies. Low EF was
identified as an independent predictor of higher short-term
mortality in some studies. In a single center study with 503 stroke
patients, systolic HF (symptoms and signs of HF and EF,50%)
was independently associated with poor outcome (mRS from 3 to
6) in 90 days with an odds ratio of 3.01 [18]. In a study with 130
stroke patients who received thrombolysis, decreased EF (EF,
40%) was independently associated with a higher 90-day mortality
rate (OR 9.88) along with the clinical diagnosis of HF (OR 4.17)
[5]. However, there are conflicting results with regard to the
relationship between reduced EF and long-term mortality. A
recent publication, evaluating stroke patients with EF#35%re-
vealed low EF is an independent predictor of 1 year mortality
along with increasing age, stroke severity and AF [6]. In contrast,
in a study with 283 stroke patients with HF, cumulative mortality
up to 10 years was not associated with low EF (EF,40%), but with
the severity of heart failure and stroke [4]. Although these studies
evaluated a direct association between low EF and long-term
mortality after stroke, they are limited by several factors. First, they
included stroke patients with heterogenous subtypes. Those with
lower EF may have a higher prevalence of CES, which can distort
the true relationship between EF and poor outcome. CES is
known to cause highest mortality and worst functional outcome
[9,10]. Our study is unique evaluating patients with single stroke
subtype. We found a significant relationship between EF and long-
term cumulative mortality in patients with CES and notably in the
subgroup with AF. Second, previous studies have arbitrary
dichotomized the EF spectrum. There is a lack of consensus with
regard to the cut-off value for defining decreased EF and various
indicators (EF,40% [5], EF,50% [18], and EF,55% [16]) have
been used as a criteria for reduced EF. Dichotomization of EF
prevents us from evaluating EF as a whole, especially those with
neither preserved nor decreased LVEF (Borderline EF) and can
result in a biased outcome. We applied EF as both continuous and
categorical variable to evaluate a true association between EF and
outcome after CES and found a significant association even when
possible covariates were adjusted. We also evaluated EF as a
categorical variable to further evaluate the true relation between
EF and stroke outcome. As expected, the association between
reduced EF#40% and long-term mortality was high. Patients with
borderline EF (41,49%) showed a tendency of higher mortality
than patients in the normal EF group, which was neglected in the
previous studies. This reinforces the concept that lower EF is
related with a higher mortality in CES. In the AF subgroup,
decreased EF had a weaker association with long-term mortality
compared with total CES patients. AF itself is known to cause
greater disability and mortality in stroke patients [20,21]. In our
study population, patients with AF had higher vascular risk burden
and worse deficits than non-AF patients. Influence of AF may have
masked the effect of lower EF on mortality. Nonetheless, it is
important to note that low EF is an independent predictor of long-
term mortality even in the AF subgroup.
There are several explanations for a poor outcome after stroke
in patients with decreased cardiac function. Patients with
decreased EF have elevated LV filling pressure, causing decreased
stroke volume. Moreover, decreased EF impairs cerebrovascular
reactivity, compromising cerebral autoregulation, eventually
causing chronic cerebral hypoperfusion [22,23]. Some investiga-
tors explain that patients with low EF are complicated with other
co-morbidities that increase atherosclerotic burden, though this
was not significant in our study.
There are some limitations in our study. First, this study is a
single-center study and our result has to be confirmed in other
populations. Also Stroke recurrence was not evaluated in this study
as a common complication among CES patients causing high
mortality [2]. Although we included previous stroke as a covariate
in the analysis, to document stroke recurrence after enrollment
was impossible through registry data. Cause of death was not
properly evaluated. Even though mortality data are partial, a
higher HR of decreased EF on vascular mortality suggests more
CES patients with decreased EF died due to vascular causes. In
addition, baseline functional status was not considered in our study
and the discharge mRS data were used as short-term outcome
instead of the 3 months mRS. Other inevitable limitations are
possible selection bias of a single center study and the possibility of
missing confounding factors while applying multivariate logistic
analysis.
Conclusions
A strong association was found between lower EF and outcome
after CES. As expected, decreased EF (EF#40%) had a strong
relationship with higher mortality. Patients with borderline EF (EF
41,49%) showed a tendency of higher mortality which has not
been evaluated in previous studies. This result was independent of
patient age, sex, vascular risk factors, stroke severity, in-hospital
management and hemorrhagic transformation. Moreover, we
found associations in the subgroup of patients with AF, which are
known to have higher mortality. No significant association was
found between borderline EF and long-term mortality in the AF
subgroup. Taken together, our study suggests the importance of
echocardiographic evaluation in CES patients, even in patients
with AF.
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